Michael Narachi
Director at Ultragenyx Pharmaceutical Inc. (RARE)
Michael Narachi has filed 6 insider reports with the SEC since June 2021, as director at Ultragenyx Pharmaceutical Inc. (RARE). The latest filing, on May 18, 2026, reports grant or award at Ultragenyx Pharmaceutical Inc. (RARE).
- Filings
- 6
- Companies
- 1
- Bought on market
- None
- Sold on market
- None
Companies where Michael Narachi is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Director | 40,441 | $16.48 | May 18, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- May 14, 2026RAREDirector Narachi Michael was granted 7,751 shares, increasing direct ownership by 24% to 40,441 unitsForm 4Grant or award
- May 15, 2025RAREDirector Narachi Michael was granted 5,740 shares, increasing direct ownership by 21% to 32,690 unitsForm 4Grant or award
- Jun 18, 2024RAREDirector Narachi Michael was granted 5,345 shares, increasing direct ownership by 25% to 26,950 unitsForm 4Grant or award
- Jun 7, 2023RARESEC Form 4 filed by Narachi MichaelForm 4Grant or award
- Jun 24, 2022RARESEC Form 4: Narachi Michael was granted 3,300 shares, increasing direct ownership by 23% to 17,745 unitsForm 4Grant or award
- Jun 24, 2021RARESEC Form 4: NARACHI MICHAEL was granted 2,145 units of Common Stock, increasing direct ownership by 17% to 14,445 unitsForm 4Grant or award
Compare Michael Narachi with
- Michael Narachi vs Theodore Alan Huizenga1 shared
- Michael Narachi vs Karah Herdman Parschauer1 shared
- Michael Narachi vs Howard Horn1 shared
- Michael Narachi vs Sanders Corazon (Corsee) D.1 shared
- Michael Narachi vs Matthew K Fust1 shared
- Michael Narachi vs Shehnaaz Suliman1 shared
Other insiders at the same companies
- Theodore Alan HuizengaRARE
- Karah Herdman ParschauerRARE
- Howard HornRARE
- Sanders Corazon (Corsee) D.RARE
- Matthew K FustRARE
- Shehnaaz SulimanRARE
- Amrit RayRARE
- Daniel G WelchRARE
- Deborah DunsireRARE
- Eric CrombezRARE
- Emil D KakkisRARE
- Dennis Karl HuangRARE
- John Richard PinionRARE
- Erik HarrisRARE
- Thomas Richard KassbergRARE
Questions about Michael Narachi
- What is Michael Narachi's role at Ultragenyx Pharmaceutical Inc.?
- Michael Narachi reports to the SEC as director at Ultragenyx Pharmaceutical Inc. (RARE), according to the latest filing on May 18, 2026.
- How many shares does Michael Narachi own?
- After the latest filing that states it, Michael Narachi directly owned 40,441 shares of Ultragenyx Pharmaceutical Inc. (RARE). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Michael Narachi bought or sold stock recently?
- No open-market purchases or sales by Michael Narachi are on file. The filings report grant or award.
- How do I get alerts when Michael Narachi files?
- Follow Michael Narachi on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Michael Narachi (SEC CIK 0001380022). Totals count each trade once, skipping amendments whose original is on file, from Jun 28, 2021 on. View on SEC EDGAR · Get this as JSON